TrialJournal of immunology (Baltimore, Md. : 1950)2014

Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia.

Sarah Cooley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.